Top Markets
Coin of the day
Dali Pharmaceuticalco.,Ltd Dali Pharmaceuticalco.,Ltd

Dali Pharmaceuticalco.,Ltd

603963
Rang in Aktien #27019
Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the... Dali Pharmaceutical Co., Ltd. is a Chinese pharmaceutical firm engaged in the research, development, manufacturing, and distribution of medicinal products. The company specializes in injectable medications, offering a diverse portfolio of both traditional Chinese and Western formulations. This includes 20 distinct drug varieties, with a total of 44 approved specifications. Key examples from their product line are Xingnaojing, Shenmai, Astragalus, Leucocin A, and Citicoline injections. Dali Pharmaceutical also maintains a substantial intellectual property collection, holding 31 patents comprised of 11 invention patents, 16 utility models, and 3 design patents. Established in 1996, the company operates from its headquarters located in Dali, China.
Aktienkurs
$0.16240909
Zuletzt synchronisiert: 2025-03-04
Marktkapitalisierung
$35.68M
Veränderung (1 Tag)
0.27%
Veränderung (1 Jahr)
0.00%
Land
CN
Handel Dali Pharmaceuticalco.,Ltd (603963)

Kategorie

Kursverlauf für Dali Pharmaceuticalco.,Ltd (603963)
Höchster Schlusskurs: $0.16 am 2025-03-01

Niedrigster Schlusskurs: $1.60 am 2017-09-01
Kursverlauf der Aktie von Dali Pharmaceuticalco.,Ltd von 2017 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2025 -60.71%
2024 -75.24%
2023 -20.50%
2022 74.98%
2021 -4.82%
2020 2.68%
2019 13.93%
2018 -41.09%
2017 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
$171.67 -
DE
$161.91 24.45%
DE
$38.00 22.72%
JP
$224.15 35.39%
CH
$21.01 11.96%
IN